A. Callejo

Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC

E. Felip, S. Cedrés, A. Navarro, 2023, Molecular oncology.

Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.

R. Dziadziuszko, J. Mazières, P. Garrido, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients

E. Felip, P. Nuciforo, R. Dienstmann, 2023, Cancers.

Correlation between immune-related adverse events (irAEs) and efficacy in patients with solid tumors treated with immune-checkpoints inhibitors (ICIs).

O. Gallego, A. Barnadas, D. Páez, 2018 .

Factores de riesgo de deterioro cognitivo asociado a cáncer en pacientes con carcinoma de mama y colon que reciben tratamiento con quimioterapia

R. Andrés, D. Isla, S. Menao, 2023, Anales del sistema sanitario de Navarra.